Guiding cancer care better.
Appropriateness of care. It’s what we are all striving for. Appropriateness of care includes giving the right treatment to the right person at the right time. It’s good for patients, good for doctors, good for insurers.
Oncologists use their experience and judgement to select the best treatments for their patients. But sometimes those treatments can be toxic and seriously affect their patients’ quality of life. And, they can be costly.
What if there was a better way?
By developing tools for Precision Medicine, we can identify the right person for the right treatment. Qualisure Diagnostics is dedicated to creating those tools. Using cutting edge machine-learning approaches, we decode the tumor’s genome, identifying the unique molecular signatures that predict how a person’s cancer will behave. We use those signatures to engineer our clinical tests. And our clinical tests have the capability to guide important clinical decisions, helping health care teams decide on the best, most appropriate treatment that will ultimately have the best outcome with the least toxic effects.